Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high1H relaxivity

Bioconjugate Chemistry

Volumn 20, Issue 6, 2009, Pages 1186-1193

  Shu, Chunying ^a   Corwin, Frank D ^b   Zhang, Jianfei ^a   Chen, Zhijian ^c   Reid, Jonathan E ^a   Sun, Minghao ^b   Xu, Wei ^d   Jae, Hyun Sim ^a   Wang, Chunru ^d   Fatouros, Panos P ^b   Esker, Alan R ^a   Gibson, Harry W ^a   Dorn, Harry C ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTE OF CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYLATION; LIGHT SCATTERING; MAGNETIC RESONANCE IMAGING;

AGENT BASED; FACILE METHOD; FACILE PREPARATION; GADOFULLERENES; MAGNETIC RESONANCE IMAGING CONTRAST AGENTS; METALLOFULLERENES; RELAXIVITY; SYNTHESISED; TEMPLATED; TRIMETALLIC NITRIDES;

FULLERENES;

AGAROSE; CONTRAST MEDIUM; FULLERENE; FULLERENE DERIVATIVE; GADODIAMIDE; GADOFOSVESET; GADOFULLERENE DERIVATIVE; GADOLINIUM; GADOLINIUM BENZYLOXYPROPIONICTETRAACETATE; GADOLINIUM PENTETATE; HYDROGEN; METALLOFULLERENENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXYLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PH MEASUREMENT; RAT; ULTRAVIOLET SPECTROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 67649195721     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900051d     Document Type: Article

References (53)

1. Caravan, P., Ellision, J. J., McMurry, T. J., and Lauffer, R. B. (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99, 2293-2352. (Pubitemid 30498114)
2. Franano, F. N., Edwards, W. B., Welch, M. J., Brechbiel, M. W., Gansow, O. A., and Duncan, J. R. (1995) Biodistribution and metabolism of targeted and nontargeted protein-chelated-gadolinium complexes-Evidence for gadolinium dissociation in vitro and in vivo. Magn. Reson. Imaging 13, 201-214.
3. 3+-diethylenetriaminepentaacetic acid and dextran. 2. Influence of spacer arm length and conjugate molecular mass on the paramagnetic properties and some biological parameters. Bioconjugate Chem. 9, 94-99.
4. Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging (MRI): marketed as Magnevist, MultiHance, Omniscan, OptiMARK, ProHance; http://www.fda.gov/medwatch/safety/2007/safety07.htm#Gadolinium.
5. Sosnovik, D. E., and Weissleder, R. (2007) Emerging concepts in molecular MRI. Curr. Opin. Biotechnol. 18, 4-10. (Pubitemid 46227964)
6. Anderson, S. A., Lee, K. K., and Frank, J. A. (2006) Gadolinium- fullerenol as a paramagnetic contrast agent for cellular imaging. Invest. Radiol. 41, 332-338. (Pubitemid 44406195)
7. Sitharaman, B., Tran, L. A., Pham, Q. P., Bolskar, R. D., Muthupillai, R., Flamm, S. D., Mikos, A. G., and Wilson, L. J. (2007) Gadofullerenes as nanoscale magnetic labels for cellular MRI. Contr. Media Mol. Imag, 2, 139-146. (Pubitemid 47180346)
8. Hartman, K. B., Wilson, L. J., and Rosenblum, M. G. (2008) Detecting and treating cancer with nanotechnology. Mol. Diagn. Ther. 12, 1-14. (Pubitemid 351281695)
9. Uggeri, F., Aime, S., Anelli, P. L., Botta, M., Brocchetta, M., Dehaen, C., Ermondi, G., Grandi, M., and Paoli, P. (1995) Novel contrast agents for magnetic resonance imaging. Synthesis and characterization of the ligand BOPTA and its Ln(III) complexes (Ln = Gd, La, Lu). X-ray structure of disodium (TPS-9-145337286-C-S)-[4-carboxyl-5,8,11-tri(carboxymethyl)-1-phenyl-2-oxa-5,8, 11-triazatridecan-13-oato(5-)]gadolinate(2-) in a mixture with its enantiomer. Inorg. Chem. 34, 633-642.
10. Cavagna, F. M., Maggioni, F., Castelli, P. M., Dapra, M., Imperatori, L. G., Lorusso, V., and Jenkins, B. G. (1997) Gadolinium chelates with weak binding to serum proteins - A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest. Radiol. 32, 780-796. (Pubitemid 28053510)
11. Pintaske, J., Martirosian, P., Graf, H., Erb, G., Lodemann, K. P., Claussen, C. D., and Schick, F. (2006) Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 T. Invest. Radiol. 41, 213-221. (Pubitemid 44406181)
12. Giesel, F. L., von Tengg-Kobligk, H.,Wilkinson, I. D., Siegler, P., von der Lieth, C. W., Frank, M., Lodemann, K. P., and Essig, M. (2006) Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents. Invest. Radiol. 41, 222-228. (Pubitemid 44406182)
13. Parmelee, D. J., Walovitch, R. C., Ouellet, H. S., and Lauffer, R. B. (1997) Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest. Radiol. 32, 741-747. (Pubitemid 28053505)
14. Lauffer, R. B., Parmelee, D. J., Dunham, S. U., Ouellet, H. S., Dolan, R. P., Witte, S., McMurry, T. J., and Walovitch, R. C. (1998) MS-325: Albumin-targeted contrast agent for MR angiography. Radiology 207, 529-538. (Pubitemid 28259074)
15. Caravan, P., Cloutier, N. J., Greenfield, M. T., McDermid, S. A., Dunham, S. U., Bulte, J. W. M., Amedio, J. C., Looby, R. J., Supkowski, R. M., Horrocks, W. D., McMurry, T. J., and Lauffer, R. B. (2002) The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J. Am. Chem. Soc. 124, 3152-3162. (Pubitemid 34249987)
16. Zhang, S. R., Sun, D. Y., Li, X. Y., Pei, F. K., and Liu, S. Y. (1997) Synthesis and solvent enhanced relaxation property of water-soluble endohedral metallofullerenols. Fullerene Sci. Technol. 5, 1635-1643. (Pubitemid 127593844)
17. Wilson, L. J. (1999) Medical application of fullerenes and metallofullerenes. Electrochem. Soc. Interface (Winter), 24-28.
18. Mikawa, M., Kato, H., Okumura, M., Narazaki, M., Kanazawa, Y., Miwa, N., and Shinohara, H. (2001) Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem. 12, 510-514. (Pubitemid 32704179)
19. Okumura, M., Mikawa, M., Yokawa, T., Kanazawa, Y., Kato, H., and Shinohara, H. (2002) Evaluation of water-soluble metallofullerenes as MRI contrast agents. Academ. Radiol. 9, S495-S497. (Pubitemid 34863265)
20. Kato, H., Kanazawa, Y., Okumura, M., Taninaka, A., Yokawa, T., and Shinohara, H. (2003) Lanthanoid endohedral metallofullerenols for MRI contrast agents. J. Am. Chem. Soc. 125, 4391-4397. (Pubitemid 36512335)
21. 10 as a MRI contrast agent. J. Am. Chem. Soc. 125, 5471-5478.
22. Shu, C. Y., Gan, L. H., Wang, C. R., Pei, X. L., and Han, H. B. (2006) Synthesis and characterization of a new water-soluble endohedral metallofullerene for MRI contrast agents. Carbon 44, 496-500.
23. Fatouros, P. P., Corwin, F. D., Chen, Z. J., Broaddus, W. C., Tatum, J. L., Kettenmann, B., Ge, Z., Gibson, H. W., Russ, J. L., Leonard, A. P., Duchamp, J. C., and Dorn, H. C. (2006) In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology 240, 756-764. (Pubitemid 44267332)
24. MacFarland, D. K., Walker, K. L., Lenk, R. P., Wilson, S. R., Kumar, K., Kepley, C. L., and Garbow, J. R. (2008) Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast. J. Med. Chem. 51, 3681-3683. (Pubitemid 351956497)
25. Dunsch, L., and Yang, S. (2007) Metal nitride cluster fullerenes: Their current state and future prospects. Small 3, 1298-1320. (Pubitemid 47245519)
26. Hartman, K. B., Laus, S., Bolskar, R. D., Muthupillai, R., Helm, L., Toth, E., Merbach, A. E., and Wilson, L. J. (2008) Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. Nano Lett. 8, 415-419. (Pubitemid 351345992)
27. 82 as a magnetic resonance imaging contrast agent. Chem. Mater. 20, 2106-2109.
28. Shu, C. Y., Ma, X. Y., Zhang, J. F., Corwin, F. D., Sim, J. H., Zhang, E. Y., Dorn, H. C., Gibson, H. W., Fatouros, P. P., Wang, C. R., and Fang, X. H. (2008) Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent. Bioconjugate Chem. 19, 651-655.
29. Zhang, E. Y., Shu, C. Y., Feng, L., and Wang, C. R. (2007) Preparation and characterization of two new water-soluble endohedral metallofullerenes as magnetic resonance imaging contrast agents. J. Phys. Chem. B 111, 14223-14226.
30. n nanoparticles: Antineoplastic activity of high efficiency and low toxicity. Nano Lett. 5, 2050-2057.
31. n nanoparticles in tumor-bearing mice. Biochem. Pharmacol. 71, 872-881.
32. Stevenson, S., Rice, G., Glass, T., Harich, K., Cromer, F., Jordan, M. R., Craft, J., Hadju, E., Bible, R., Olmstead, M. M., Maitra, K., Fisher, A. J., Balch, A. L., and Dorn, H. C. (1999) Small-bandgap endohedral metallofullerenes in high yield and purity. Nature 401, 55-57. (Pubitemid 29418439)
33. Ge, Z. X., Duchamp, J. C., Cai, T., Gibson, H. W., and Dorn, H. C. (2005) Purification of endohedral trimetallic nitride fullerenes in a single, facile step. J. Am. Chem. Soc. 127, 16292-16298. (Pubitemid 41689260)
34. Clover, A. M., and Houghton, A. C. (1904) Action of hydrogen peroxide on anhydrides and the formation of organic acid, peroxides, and peracids. Am. Chem. J. 32, 43-68.
35. Xing, G. M., Zhang, J., Zhao, Y. L., Tang, J., Zhang, B., Gao, X. F., Yuan, H., Qu, L., Cao, W. B., Chai, Z. F., Ibrahim, K., and Su, R. (2004) Influences of structural properties on stability of fullerenols. J. Phys. Chem. B 108, 11473-11479.
36. Toth, E., Bolskar, R. D., Borel, A., Gonzalez, G., Helm, L., Merbach, A. E., Sitharaman, B., and Wilson, L. J. (2005) Water-soluble gadofullerenes: Toward high-relaxivity, pH-responsive MRI contrast agents. J. Am. Chem. Soc. 127, 799-805. (Pubitemid 40178748)
37. Xiao, Z., Yao, J. Y., Yang, D. Z., Wang, F. D., Huang, S. H., Gan, L. B., Jia, Z. S., Jiang, Z. P., Yang, X. B., Zheng, B., Yuan, G., Zhang, S. W., and Wang, Z. M. (2007) Synthesis of [59]fullerenones through peroxide-mediated stepwise cleavage of fullerene skeleton bonds and x-ray structures of their water-encapsulated open-cage complexes. J. Am. Chem. Soc. 129, 16149-16162.
38. Organic Peroxides (Swern, D., Ed.) (1971) Wiley-Interscience, New York.
39. + in solution. Tetrahedron Lett. 34, 7629-7632.
40. Fieser, L. F., and Turner, R. B. (1947) Naphthoquinone acids and ketols. J. Am. Chem. Soc. 69, 2338-2341.
41. Peng, H. Q., Alemany, L. B., Margrave, J. L., and Khabashesku, V. N. (2003) Sidewall carboxylic acid functionalization of single-walled carbon nanotubes. J. Am. Chem. Soc. 125, 15174-15182. (Pubitemid 37509680)
42. 3N in carbon cages: The influence of cluster size and bond strength. Angew. Chem., Int. Ed. 44, 1557-1560.
43. 80 (x = 1, 2). ChemPhysChem 7, 1990-1995.
44. 10. J. Am. Chem. Soc. 127, 9368-9369.
45. Schneider, G., Altmeyer, K., Kirchin, M. A., Seidel, R., Grazioli, L., Morana, G., and Saini, S. (2007) Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging. Invest. Radiol. 42, 105-115. (Pubitemid 46104891)
46. Toth, E., and Merbach, A. E. (2001) In The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, Wiley, Chichester.
47. Sharp, R. R. (2003) Paramagnetic NMR. Nucl. Magn. Reson. 473-519.
48. 82. Chem. J. Chin. Univ.-Chin. 25, 697-700.
49. 80, J. Appl. Phys. 101, 09E105 (1-3).
50. Qian, M. C., Ong, S. V., Khanna, S. N., and Knickelbein, M. B. (2007) Magnetic endohedral metallofullerenes with floppy interiors. Phys. Rev. B 75, 104424. 1-6.
51. Laus, S., Sitharaman, B., Toth, E., Bolskar, R. D., Helm, L., Wilson, L. J., and Merbach, A. E. (2007) Understanding paramagnetic relaxation phenomena for water-soluble gadofullerenes. J. Phys. Chem. C 111, 5633-5639. (Pubitemid 46686241)
52. x: Nanoscale aggregation studies of two metallofullerene MRI contrast agents in aqueous solution. Nano Lett. 4, 2373-2378.
53. x. J. Phys. Chem. B 110, 15597-15601.